Company News in the Life Science Industry

»

Reset 

Zelira Therapeutics Expands HOPE® Distribution In The U.S.A

PERTH, Australia, Dec. 3, 2019 /PRNewswire/ -- Zelira Therapeutics Ltd (ASX: ZLD, OTCQB: ZLDAF, Zelira), formerly Zelda Therapeutics Ltd, announced today it will bring its HOPE® Franchise to the state of Louisiana with a licensing agreement that will generate immediate revenue through a licensing... Read more ››

By: PR Newswire Association LLC. - 04 Dec 2019

Global mobile cardiac telemetry devices market is expected to grow with a CAGR of 11.60% over the forecast period from 2019-2025

The report on the global mobile cardiac telemetry devices market provides qualitative and quantitative analysis for the period from 2017 to 2025.

Read more ››
By: PR Newswire Association LLC. - 04 Dec 2019

Global MRI guided neurosurgical ablation market is expected to grow with a CAGR of 4.1% over the forecast period from 2019-2025

The report on the global MRI guided neurosurgical ablation market provides qualitative and quantitative analysis for the period from 2017 to 2025.

Read more ››
By: PR Newswire Association LLC. - 04 Dec 2019

Global nanopharmaceuticals market is expected to grow with a CAGR of 22.10% over the forecast period from 2019-2025

The report on the global nanopharmaceuticals market provides qualitative and quantitative analysis for the period from 2017 to 2025.

Read more ››
By: PR Newswire Association LLC. - 04 Dec 2019

Medifast, Inc. Announces 51 Percent Increase in Quarterly Dividend

BALTIMORE, Dec. 3, 2019 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), a leading manufacturer and distributor of clinically proven... Read more ››

By: PR Newswire Association LLC. - 04 Dec 2019
Related companies:  Medifast, Inc.

The global neurology devices market at a CAGR of almost 12% during the forecast period

NEW YORK, Dec. 3, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 04 Dec 2019

Pearl's Scan Clarity Score Reduces Time And Money Spent on Poor Quality Scans During Dental Restoration Process

WEST HOLLYWOOD, Calif., Dec. 3, 2019 /PRNewswire/ -- Pearl, the AI dental care company that is delivering AI and computer vision solutions... Read more ››

By: PR Newswire Association LLC. - 04 Dec 2019
Related companies:  PEARL STREET VENTURE FUNDS | Pearland Economic Development Corporation | PEARL THERAPEUTICS, INC.

Immunomedics Announces Proposed Public Offering of Common Stock

Read more ››
By: GlobenewsWire - 03 Dec 2019
Related companies:  Immunomedics, Inc.

Cara Therapeutics to Present at the 31st Annual Piper Jaffray Healthcare Conference

Read more ››
By: GlobenewsWire - 03 Dec 2019
Related companies:  Cara Therapeutics Inc.

SI-BONE to Participate at the 31st Annual Piper Jaffray Healthcare Conference on December 5, 2019

Read more ››
By: GlobenewsWire - 03 Dec 2019

RAPT Therapeutics and Hanmi Pharmaceutical Announce Collaboration to Develop and Commercialize FLX475 in Asia

Read more ››
By: GlobenewsWire - 03 Dec 2019
Related companies:  RAPT Therapeutics

Xenon Pharmaceuticals to Present at the 31st Annual Piper Jaffray Healthcare Conference

Read more ››
By: GlobenewsWire - 03 Dec 2019
Related companies:  Xenon Pharmaceuticals Inc.

EmCyte Announces FDA 510(k) Clearance for its Progenikine® Concentrating System for Adipose

FORT MYERS, Fla., Dec. 3, 2019 /PRNewswire/ -- EmCyte, the world leader in platelet rich plasma and progenitor stem cell biologics, announces its FDA 510(k) clearance for its Progenikine® Concentrating System for adipose lipoplasty. The system's 510(k) is cleared for all medical procedures... Read more ››

By: PR Newswire Association LLC. - 03 Dec 2019

RORZE Lifescience Partners with Biosero to Commercialize Green Button Go Automation Scheduling Software in Japan, China

SAN DIEGO, Dec. 3, 2019 /PRNewswire/ -- Biosero, Inc. announced a new partnership wherein RORZE Lifescience, Inc., a subsidiary of Rorze, Inc. (TYO: 6323), will commercialize Biosero's Green Button Go(TM) Automation Scheduling Software in Asia. RORZE Lifescience, Inc. (RLS) will adopt Green Button... Read more ››

By: PR Newswire Association LLC. - 03 Dec 2019

Global Negative Pressure Wound Therapy (NPWT) Industry

NEW YORK, Dec. 3, 2019 /PRNewswire/ -- Negative Pressure Wound Therapy (NPWT) market worldwide is projected to grow by US$819.5 Million, driven by a compounded growth of 4.9%. Conventional NPWT, one of the segments analyzed and sized in this study, displays the potential to grow at over 4.7%.... Read more ››

By: PR Newswire Association LLC. - 03 Dec 2019

Northwell launches chatbot to boost use of colonoscopy

NEW HYDE PARK, N.Y., Dec. 3, 2019 /PRNewswire/ -- Northwell Health has launched a personalized chatbot for patients with an appointment... Read more ››

By: PR Newswire Association LLC. - 03 Dec 2019

Neonatal Infant Care Device Market, Forecast to 2023

NEW YORK, Dec. 3, 2019 /PRNewswire/ -- The neonatal care market is at a juncture where the rate of innovation in devices is much lower, resulting in flat prices and mid-single digit market growth, largely driven by replacement sales.This is especially true for phototherapy units and some respiration... Read more ››

By: PR Newswire Association LLC. - 03 Dec 2019

Biostage Receives Response from the FDA for Investigational New Drug Application for its Lead Product Candidate Cellspan(TM) Esophageal Implant

HOLLISTON, Mass., Dec. 3, 2019 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a bioengineering company... Read more ››

By: PR Newswire Association LLC. - 03 Dec 2019
Related companies:  BIOSTAGE, INC.

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

BRIDGEWATER, N.J., Dec. 3, 2019 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the granting of inducement awards to six new employees. In accordance with NASDAQ... Read more ››

By: PR Newswire Association LLC. - 03 Dec 2019
Related companies:  Insmed Incorporated

Relmada Therapeutics Announces Proposed Public Offering of Common Stock

NEW YORK, Dec. 3, 2019 /PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, today announced its intention to offer and sell shares of its common stock in an underwritten public... Read more ››

By: PR Newswire Association LLC. - 03 Dec 2019
Related companies:  Relmada Therapeutics, Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17 18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies